Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
Previous non-responders or partial responders to Semaglutide
In animal studies, MOTS-c has demonstrated near-miraculous effects on metabolic health
Trying to self-administer comes with real risks, like causing an infection or injuring yourself
It differs from GHK-Cu in its amino acid sequence, and the two peptides are sometimes combined within advanced haircare formulations
A 7.5 mg dose at this concentration means injecting 1.5 mL, which is at the upper limit of what most people find comfortable for a subcutaneous injection
US$ 24.31
US$ 29.59
US$ 27.56
US$ 29.66
US$ 25.40
US$ 20.05
US$ 24.34
US$ 28.85
US$ 20.56
